Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Gross Profit
Tandem Diabetes Care Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Gross Profit
$379.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
28%
|
CAGR 10-Years
54%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$10.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is Tandem Diabetes Care Inc's Gross Profit?
Gross Profit
379.5m
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Gross Profit amounts to 379.5m USD.
What is Tandem Diabetes Care Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
54%
Over the last year, the Gross Profit growth was -6%. The average annual Gross Profit growth rates for Tandem Diabetes Care Inc have been 10% over the past three years , 28% over the past five years , and 54% over the past ten years .